APO Research
Talk to an analyst

APO RESEARCH · REPORT

Seasonal Influenza Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Seasonal Influenza Vaccines Industry Growth and Trends Forecast to 2032

19 December 2025127 pages

Choose your research edition.

Industry ResearchSeasonal Influenza Vaccines Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Seasonal Influenza Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Seasonal Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Seasonal Influenza Vaccines Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Seasonal Influenza Vaccines Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Seasonal Influenza Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Seasonal Influenza Vaccines include Changsheng Bio-Technology, Sanofi, Novartis International AG, Merck & Co., Inc., Pfizer Inc, GlaxoSmithKline plc, AstraZeneca, Viatris Inc. and Vaxess Technologies Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Seasonal Influenza Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Seasonal Influenza Vaccines market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Seasonal Influenza Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Seasonal Influenza Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Seasonal Influenza Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Seasonal Influenza Vaccines Market by Company

Changsheng Bio-Technology

Sanofi

Novartis International AG

Merck & Co., Inc.

Pfizer Inc

GlaxoSmithKline plc

AstraZeneca

Viatris Inc.

Vaxess Technologies Inc

Sinovac Biotech Ltd

SINOVAC

OSIVAX

Jiangsu Simcere Vaxtec Bio-pharmaceutical

EMERGEX VACCINES

EMERGENT

Dalian Hissen Bio-pharm

CSL Limited

Ccbio SA

Aleph Biomedical

Abbott Laboratories

Seasonal Influenza Vaccines Segment by Type

Type B

Type A (H3N2)

Type A (H1N1)

Seasonal Influenza Vaccines Segment by Application

Adults

Pediatrics

Elderly

Adolescence

Seasonal Influenza Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Seasonal Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Seasonal Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Type B Table 2. Major Company of Type A (H3N2) Table 3. Major Company of Type A (H1N1) Table 4. Global Seasonal Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 6. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global Seasonal Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global Seasonal Influenza Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global Seasonal Influenza Vaccines Price by Type (2021-2026) & (US$/Unit) Table 10. Global Seasonal Influenza Vaccines Sales by Type (2027-2032) & (W Units) Table 11. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global Seasonal Influenza Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global Seasonal Influenza Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global Seasonal Influenza Vaccines Price by Type (2027-2032) & (US$/Unit) Table 15. North America Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 16. North America Seasonal Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 18. Europe Seasonal Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Seasonal Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 22. Latin America Seasonal Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Seasonal Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Seasonal Influenza Vaccines Industry Trends Table 26. Seasonal Influenza Vaccines Industry Drivers Table 27. Seasonal Influenza Vaccines Industry Opportunities and Challenges Table 28. Seasonal Influenza Vaccines Industry Restraints Table 29. Global Seasonal Influenza Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Seasonal Influenza Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global Seasonal Influenza Vaccines Sales by Company (2021-2026) & (W Units) Table 32. Global Seasonal Influenza Vaccines Sales Share by Company (2021-2026) Table 33. Global Seasonal Influenza Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Seasonal Influenza Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Seasonal Influenza Vaccines Major Company Production Sites and Headquarters Table 36. Global Seasonal Influenza Vaccines Company, Product Type & Application Table 37. Global Seasonal Influenza Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Seasonal Influenza Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Seasonal Influenza Vaccines Sales by Region (2021-2026) & (W Units) Table 42. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global Seasonal Influenza Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global Seasonal Influenza Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Seasonal Influenza Vaccines Sales by Region (2027-2032) & (W Units) Table 47. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global Seasonal Influenza Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global Seasonal Influenza Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Seasonal Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 53. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global Seasonal Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global Seasonal Influenza Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global Seasonal Influenza Vaccines Price by Application (2021-2026) & (US$/Unit) Table 57. Global Seasonal Influenza Vaccines Sales by Application (2027-2032) & (W Units) Table 58. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global Seasonal Influenza Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global Seasonal Influenza Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global Seasonal Influenza Vaccines Price by Application (2027-2032) & (US$/Unit) Table 62. North America Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 63. North America Seasonal Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 65. Europe Seasonal Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Seasonal Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 69. Latin America Seasonal Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Seasonal Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Changsheng Bio-Technology Company Information Table 73. Changsheng Bio-Technology Business Overview Table 74. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio Table 76. Changsheng Bio-Technology Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sanofi Seasonal Influenza Vaccines Product Portfolio Table 81. Sanofi Recent Development Table 82. Novartis International AG Company Information Table 83. Novartis International AG Business Overview Table 84. Novartis International AG Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Novartis International AG Seasonal Influenza Vaccines Product Portfolio Table 86. Novartis International AG Recent Development Table 87. Merck & Co., Inc. Company Information Table 88. Merck & Co., Inc. Business Overview Table 89. Merck & Co., Inc. Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio Table 91. Merck & Co., Inc. Recent Development Table 92. Pfizer Inc Company Information Table 93. Pfizer Inc Business Overview Table 94. Pfizer Inc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pfizer Inc Seasonal Influenza Vaccines Product Portfolio Table 96. Pfizer Inc Recent Development Table 97. GlaxoSmithKline plc Company Information Table 98. GlaxoSmithKline plc Business Overview Table 99. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio Table 101. GlaxoSmithKline plc Recent Development Table 102. AstraZeneca Company Information Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. AstraZeneca Seasonal Influenza Vaccines Product Portfolio Table 106. AstraZeneca Recent Development Table 107. Viatris Inc. Company Information Table 108. Viatris Inc. Business Overview Table 109. Viatris Inc. Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Viatris Inc. Seasonal Influenza Vaccines Product Portfolio Table 111. Viatris Inc. Recent Development Table 112. Vaxess Technologies Inc Company Information Table 113. Vaxess Technologies Inc Business Overview Table 114. Vaxess Technologies Inc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio Table 116. Vaxess Technologies Inc Recent Development Table 117. Sinovac Biotech Ltd Company Information Table 118. Sinovac Biotech Ltd Business Overview Table 119. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio Table 121. Sinovac Biotech Ltd Recent Development Table 122. SINOVAC Company Information Table 123. SINOVAC Business Overview Table 124. SINOVAC Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. SINOVAC Seasonal Influenza Vaccines Product Portfolio Table 126. SINOVAC Recent Development Table 127. OSIVAX Company Information Table 128. OSIVAX Business Overview Table 129. OSIVAX Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. OSIVAX Seasonal Influenza Vaccines Product Portfolio Table 131. OSIVAX Recent Development Table 132. Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information Table 133. Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview Table 134. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio Table 136. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development Table 137. EMERGEX VACCINES Company Information Table 138. EMERGEX VACCINES Business Overview Table 139. EMERGEX VACCINES Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio Table 141. EMERGEX VACCINES Recent Development Table 142. EMERGENT Company Information Table 143. EMERGENT Business Overview Table 144. EMERGENT Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. EMERGENT Seasonal Influenza Vaccines Product Portfolio Table 146. EMERGENT Recent Development Table 147. Dalian Hissen Bio-pharm Company Information Table 148. Dalian Hissen Bio-pharm Business Overview Table 149. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio Table 151. Dalian Hissen Bio-pharm Recent Development Table 152. CSL Limited Company Information Table 153. CSL Limited Business Overview Table 154. CSL Limited Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. CSL Limited Seasonal Influenza Vaccines Product Portfolio Table 156. CSL Limited Recent Development Table 157. Ccbio SA Company Information Table 158. Ccbio SA Business Overview Table 159. Ccbio SA Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Ccbio SA Seasonal Influenza Vaccines Product Portfolio Table 161. Ccbio SA Recent Development Table 162. Aleph Biomedical Company Information Table 163. Aleph Biomedical Business Overview Table 164. Aleph Biomedical Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio Table 166. Aleph Biomedical Recent Development Table 167. Abbott Laboratories Company Information Table 168. Abbott Laboratories Business Overview Table 169. Abbott Laboratories Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio Table 171. Abbott Laboratories Recent Development Table 172. North America Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 173. North America Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 174. North America Seasonal Influenza Vaccines Sales Market Share by Country (2021-2026) Table 175. North America Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 176. North America Seasonal Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 177. North America Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. North America Seasonal Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 179. North America Seasonal Influenza Vaccines Market Share by Country (2021-2026) Table 180. North America Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. North America Seasonal Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 182. Europe Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 183. Europe Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 184. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2021-2026) Table 185. Europe Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 186. Europe Seasonal Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 187. Europe Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Europe Seasonal Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 189. Europe Seasonal Influenza Vaccines Market Share by Country (2021-2026) Table 190. Europe Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Europe Seasonal Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 192. Asia-Pacific Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 193. Asia-Pacific Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 194. Asia-Pacific Seasonal Influenza Vaccines Sales Market Share by Country (2021-2026) Table 195. Asia-Pacific Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 196. Asia-Pacific Seasonal Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 197. Asia-Pacific Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Asia-Pacific Seasonal Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 199. Asia-Pacific Seasonal Influenza Vaccines Market Share by Country (2021-2026) Table 200. Asia-Pacific Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Asia-Pacific Seasonal Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 202. Latin America Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 203. Latin America Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 204. Latin America Seasonal Influenza Vaccines Sales Market Share by Country (2021-2026) Table 205. Latin America Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 206. Latin America Seasonal Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 207. Latin America Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Latin America Seasonal Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 209. Latin America Seasonal Influenza Vaccines Market Share by Country (2021-2026) Table 210. Latin America Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Latin America Seasonal Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 212. Middle East and Africa Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 213. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 214. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Country (2021-2026) Table 215. Middle East and Africa Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 216. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 217. Middle East and Africa Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 218. Middle East and Africa Seasonal Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 219. Middle East and Africa Seasonal Influenza Vaccines Market Share by Country (2021-2026) Table 220. Middle East and Africa Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 221. Middle East and Africa Seasonal Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Seasonal Influenza Vaccines Distributors List Table 225. Seasonal Influenza Vaccines Customers List Table 226. Research Programs/Design for This Report Table 227. Authors List of This Report Table 228. Secondary Sources Table 229. Primary Sources List of Figures Figure 1. Seasonal Influenza Vaccines Image Figure 2. Global Seasonal Influenza Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Seasonal Influenza Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Seasonal Influenza Vaccines Sales (2021-2032) & (W Units) Figure 5. Type B Image Figure 6. Global Type B Sales YoY Growth (2021-2032) & (W Units) Figure 7. Type A (H3N2) Image Figure 8. Global Type A (H3N2) Sales YoY Growth (2021-2032) & (W Units) Figure 9. Type A (H1N1) Image Figure 10. Global Type A (H1N1) Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Seasonal Influenza Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Seasonal Influenza Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America Seasonal Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America Seasonal Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe Seasonal Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe Seasonal Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Seasonal Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Seasonal Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America Seasonal Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Seasonal Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Seasonal Influenza Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adults Image Figure 26. Global Adults Sales YoY Growth (2021-2032) & (W Units) Figure 27. Pediatrics Image Figure 28. Global Pediatrics Sales YoY Growth (2021-2032) & (W Units) Figure 29. Elderly Image Figure 30. Global Elderly Sales YoY Growth (2021-2032) & (W Units) Figure 31. Adolescence Image Figure 32. Global Adolescence Sales YoY Growth (2021-2032) & (W Units) Figure 33. Global Seasonal Influenza Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Seasonal Influenza Vaccines Market Share by Application 2025 VS 2032 Figure 35. North America Seasonal Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. North America Seasonal Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Europe Seasonal Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Europe Seasonal Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Seasonal Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Seasonal Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Latin America Seasonal Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Seasonal Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 45. North America Seasonal Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. North America Seasonal Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Seasonal Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Seasonal Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Europe Seasonal Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Seasonal Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Seasonal Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Asia-Pacific Seasonal Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Seasonal Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Seasonal Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Latin America Seasonal Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Seasonal Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Seasonal Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Middle East and Africa Seasonal Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Seasonal Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Seasonal Influenza Vaccines Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Seasonal Influenza Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Type B
  • Type A (H3N2)
  • Type A (H1N1)
Applications
  • Adults
  • Pediatrics
  • Elderly
  • Adolescence
Companies covered
  • Changsheng Bio-Technology
  • Sanofi
  • Novartis International AG
  • Merck & Co., Inc.
  • Pfizer Inc
  • GlaxoSmithKline plc
  • AstraZeneca
  • Viatris Inc.
  • Vaxess Technologies Inc
  • Sinovac Biotech Ltd
  • SINOVAC
  • OSIVAX
  • Jiangsu Simcere Vaxtec Bio-pharmaceutical
  • EMERGEX VACCINES
  • EMERGENT
  • Dalian Hissen Bio-pharm
  • CSL Limited
  • Ccbio SA
  • Aleph Biomedical
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Seasonal Influenza Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Seasonal Influenza Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Seasonal Influenza Vaccines Market by Type
  6. 1.3.1 Type B
  7. 1.3.2 Type A (H3N2)
  8. 1.3.3 Type A (H1N1)
  9. 1.4 Global Seasonal Influenza Vaccines Market Size by Type
  10. 1.4.1 Global Seasonal Influenza Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Seasonal Influenza Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Seasonal Influenza Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Seasonal Influenza Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Seasonal Influenza Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Seasonal Influenza Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Seasonal Influenza Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Seasonal Influenza Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Seasonal Influenza Vaccines Industry Trends
  2. 2.2 Seasonal Influenza Vaccines Industry Drivers
  3. 2.3 Seasonal Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Seasonal Influenza Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Seasonal Influenza Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Seasonal Influenza Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Seasonal Influenza Vaccines Price (2021-2026)
  4. 3.4 Global Seasonal Influenza Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Seasonal Influenza Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Seasonal Influenza Vaccines Company, Product Type & Application
  7. 3.7 Global Seasonal Influenza Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Seasonal Influenza Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Seasonal Influenza Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Seasonal Influenza Vaccines Tier 1, Tier 2, and Tier 3
4 Seasonal Influenza Vaccines Regional Status and Outlook
  1. 4.1 Global Seasonal Influenza Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Seasonal Influenza Vaccines Historic Market Size by Region
  3. 4.2.1 Global Seasonal Influenza Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Seasonal Influenza Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Seasonal Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Seasonal Influenza Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Seasonal Influenza Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Seasonal Influenza Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Seasonal Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Seasonal Influenza Vaccines by Application
  1. 5.1 Seasonal Influenza Vaccines Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Pediatrics
  4. 5.1.3 Elderly
  5. 5.1.4 Adolescence
  6. 5.2 Global Seasonal Influenza Vaccines Market Size by Application
  7. 5.2.1 Global Seasonal Influenza Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Seasonal Influenza Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Seasonal Influenza Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Seasonal Influenza Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Seasonal Influenza Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Seasonal Influenza Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Seasonal Influenza Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Seasonal Influenza Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Changsheng Bio-Technology
  2. 6.1.1 Changsheng Bio-Technology Company Information
  3. 6.1.2 Changsheng Bio-Technology Business Overview
  4. 6.1.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
  6. 6.1.5 Changsheng Bio-Technology Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Seasonal Influenza Vaccines Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis International AG
  14. 6.3.1 Novartis International AG Company Information
  15. 6.3.2 Novartis International AG Business Overview
  16. 6.3.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio
  18. 6.3.5 Novartis International AG Recent Developments
  19. 6.4 Merck & Co., Inc.
  20. 6.4.1 Merck & Co., Inc. Company Information
  21. 6.4.2 Merck & Co., Inc. Business Overview
  22. 6.4.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
  24. 6.4.5 Merck & Co., Inc. Recent Developments
  25. 6.5 Pfizer Inc
  26. 6.5.1 Pfizer Inc Company Information
  27. 6.5.2 Pfizer Inc Business Overview
  28. 6.5.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
  30. 6.5.5 Pfizer Inc Recent Developments
  31. 6.6 GlaxoSmithKline plc
  32. 6.6.1 GlaxoSmithKline plc Company Information
  33. 6.6.2 GlaxoSmithKline plc Business Overview
  34. 6.6.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
  36. 6.6.5 GlaxoSmithKline plc Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Seasonal Influenza Vaccines Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Viatris Inc.
  44. 6.8.1 Viatris Inc. Company Information
  45. 6.8.2 Viatris Inc. Business Overview
  46. 6.8.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
  48. 6.8.5 Viatris Inc. Recent Developments
  49. 6.9 Vaxess Technologies Inc
  50. 6.9.1 Vaxess Technologies Inc Company Information
  51. 6.9.2 Vaxess Technologies Inc Business Overview
  52. 6.9.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
  54. 6.9.5 Vaxess Technologies Inc Recent Developments
  55. 6.10 Sinovac Biotech Ltd
  56. 6.10.1 Sinovac Biotech Ltd Company Information
  57. 6.10.2 Sinovac Biotech Ltd Business Overview
  58. 6.10.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
  60. 6.10.5 Sinovac Biotech Ltd Recent Developments
  61. 6.11 SINOVAC
  62. 6.11.1 SINOVAC Company Information
  63. 6.11.2 SINOVAC Business Overview
  64. 6.11.3 SINOVAC Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 SINOVAC Seasonal Influenza Vaccines Product Portfolio
  66. 6.11.5 SINOVAC Recent Developments
  67. 6.12 OSIVAX
  68. 6.12.1 OSIVAX Company Information
  69. 6.12.2 OSIVAX Business Overview
  70. 6.12.3 OSIVAX Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 OSIVAX Seasonal Influenza Vaccines Product Portfolio
  72. 6.12.5 OSIVAX Recent Developments
  73. 6.13 Jiangsu Simcere Vaxtec Bio-pharmaceutical
  74. 6.13.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
  75. 6.13.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview
  76. 6.13.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
  78. 6.13.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
  79. 6.14 EMERGEX VACCINES
  80. 6.14.1 EMERGEX VACCINES Company Information
  81. 6.14.2 EMERGEX VACCINES Business Overview
  82. 6.14.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
  84. 6.14.5 EMERGEX VACCINES Recent Developments
  85. 6.15 EMERGENT
  86. 6.15.1 EMERGENT Company Information
  87. 6.15.2 EMERGENT Business Overview
  88. 6.15.3 EMERGENT Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 EMERGENT Seasonal Influenza Vaccines Product Portfolio
  90. 6.15.5 EMERGENT Recent Developments
  91. 6.16 Dalian Hissen Bio-pharm
  92. 6.16.1 Dalian Hissen Bio-pharm Company Information
  93. 6.16.2 Dalian Hissen Bio-pharm Business Overview
  94. 6.16.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
  96. 6.16.5 Dalian Hissen Bio-pharm Recent Developments
  97. 6.17 CSL Limited
  98. 6.17.1 CSL Limited Company Information
  99. 6.17.2 CSL Limited Business Overview
  100. 6.17.3 CSL Limited Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 CSL Limited Seasonal Influenza Vaccines Product Portfolio
  102. 6.17.5 CSL Limited Recent Developments
  103. 6.18 Ccbio SA
  104. 6.18.1 Ccbio SA Company Information
  105. 6.18.2 Ccbio SA Business Overview
  106. 6.18.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio
  108. 6.18.5 Ccbio SA Recent Developments
  109. 6.19 Aleph Biomedical
  110. 6.19.1 Aleph Biomedical Company Information
  111. 6.19.2 Aleph Biomedical Business Overview
  112. 6.19.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
  114. 6.19.5 Aleph Biomedical Recent Developments
  115. 6.20 Abbott Laboratories
  116. 6.20.1 Abbott Laboratories Company Information
  117. 6.20.2 Abbott Laboratories Business Overview
  118. 6.20.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
  120. 6.20.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Seasonal Influenza Vaccines Sales by Country
  2. 7.1.1 North America Seasonal Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Seasonal Influenza Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Seasonal Influenza Vaccines Market Size by Country
  6. 7.2.1 North America Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Seasonal Influenza Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Seasonal Influenza Vaccines Sales by Country
  2. 8.1.1 Europe Seasonal Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Seasonal Influenza Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Seasonal Influenza Vaccines Market Size by Country
  6. 8.2.1 Europe Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Seasonal Influenza Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Seasonal Influenza Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Seasonal Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Seasonal Influenza Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Seasonal Influenza Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Seasonal Influenza Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Seasonal Influenza Vaccines Sales by Country
  2. 10.1.1 South America Seasonal Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Seasonal Influenza Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Seasonal Influenza Vaccines Market Size by Country
  6. 10.2.1 South America Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Seasonal Influenza Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Seasonal Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Seasonal Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Seasonal Influenza Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Seasonal Influenza Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Seasonal Influenza Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Seasonal Influenza Vaccines Value Chain Analysis
  2. 12.1.1 Seasonal Influenza Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Seasonal Influenza Vaccines Production Mode & Process
  7. 12.2 Seasonal Influenza Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Seasonal Influenza Vaccines Distributors
  10. 12.2.3 Seasonal Influenza Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst